Shared senior authorship.
Significance of cytomegalovirus infection in the failure of native arteriovenous fistula
Article first published online: 9 NOV 2011
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases
Clinical Microbiology and Infection
Volume 18, Issue 1, pages E5–E7, January 2012
How to Cite
Dzabic, M., Bojakowski, K., Kurzejamska, E., Styczynski, G., Andziak, P., Söderberg-Nauclér, C. and Religa, P. (2012), Significance of cytomegalovirus infection in the failure of native arteriovenous fistula. Clinical Microbiology and Infection, 18: E5–E7. doi: 10.1111/j.1469-0691.2011.03691.x
- Issue published online: 14 DEC 2011
- Article first published online: 9 NOV 2011
- Accepted manuscript online: 4 OCT 2011 10:30AM EST
- Original Submission: 16 June 2011; Revised Submission: 14 September 2011; Accepted: 30 September 20111 Editor: L. Kaiser Article published online: 5 October 2011
- Arteriovenous fistula;
Clin Microbiol Infect 2012; 18: E5–E7
High cytomegalovirus (CMV) IgG levels have been identified as a risk factor for arteriovenous fistula (AVF) failure. None of the 68 patents in our study were CMV IgM positive, although 96% were CMV IgG positive. CMV antigens were detected in the radial artery or cephalic vein of 46% of patients who received an AVF. The presence of CMV antigens or high serum CMV IgG levels had no prognostic value for AVF failure.